Global RNAi for Therapeutic Market Research Report 2016

October 2016 | 115 pages | ID: GE31F13FBB2EN
QYResearch

Abstracts

Notes:

Production, means the output of RNAi for Therapeutic

Revenue, means the sales value of RNAi for Therapeutic

This report studies RNAi for Therapeutic in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Alnylam Pharmaceuticals
• Arbutus Biopharma (Tekmira)
• Arrowhead Research
• Dicerna Pharmaceuticals
• Mirna Therapeutics
• Quark Pharmaceuticals
• RXi Pharmaceuticals
• Silence Therapeutics
• Benitec Biopharma
• Miragen Therapeutics
• Sylentis
• Gradalis
• Sirnaomics
• Silenseed

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of RNAi for Therapeutic in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• siRNA
• miRNA
• shRNA

Split by application, this report focuses on consumption, market share and growth rate of RNAi for Therapeutic in each application, can be divided into

• Cancer
• Cardiovascular
• HBV

Contents

Global RNAi for Therapeutic Market Research Report 2016

1 RNAI FOR THERAPEUTIC MARKET OVERVIEW

1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 RNAi for Therapeutic Segment by Type
  1.2.1 Global Production Market Share of RNAi for Therapeutic by Type in 2015
  1.2.2 siRNA
  1.2.3 miRNA
  1.2.4 shRNA
1.3 RNAi for Therapeutic Segment by Application
  1.3.1 RNAi for Therapeutic Consumption Market Share by Application in 2015
  1.3.2 Cancer
  1.3.3 Cardiovascular
  1.3.4 HBV
1.4 RNAi for Therapeutic Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of RNAi for Therapeutic (2011-2021)

2 GLOBAL RNAI FOR THERAPEUTIC MARKET COMPETITION BY MANUFACTURERS

2.1 Global RNAi for Therapeutic Production and Share by Manufacturers (2015 and 2016)
2.2 Global RNAi for Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global RNAi for Therapeutic Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers RNAi for Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 RNAi for Therapeutic Market Competitive Situation and Trends
  2.5.1 RNAi for Therapeutic Market Concentration Rate
  2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RNAI FOR THERAPEUTIC PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global RNAi for Therapeutic Production by Region (2011-2016)
3.2 Global RNAi for Therapeutic Production Market Share by Region (2011-2016)
3.3 Global RNAi for Therapeutic Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL RNAI FOR THERAPEUTIC SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global RNAi for Therapeutic Consumption by Regions (2011-2016)
4.2 North America RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL RNAI FOR THERAPEUTIC PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global RNAi for Therapeutic Production and Market Share by Type (2011-2016)
5.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
5.3 Global RNAi for Therapeutic Price by Type (2011-2016)
5.4 Global RNAi for Therapeutic Production Growth by Type (2011-2016)

6 GLOBAL RNAI FOR THERAPEUTIC MARKET ANALYSIS BY APPLICATION

6.1 Global RNAi for Therapeutic Consumption and Market Share by Application (2011-2016)
6.2 Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RNAI FOR THERAPEUTIC MANUFACTURERS PROFILES/ANALYSIS

7.1 Alnylam Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 RNAi for Therapeutic Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Arbutus Biopharma (Tekmira)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 RNAi for Therapeutic Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Arrowhead Research
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 RNAi for Therapeutic Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Arrowhead Research RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Dicerna Pharmaceuticals
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 RNAi for Therapeutic Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Mirna Therapeutics
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 RNAi for Therapeutic Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Mirna Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Quark Pharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 RNAi for Therapeutic Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 RXi Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 RNAi for Therapeutic Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Silence Therapeutics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 RNAi for Therapeutic Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Silence Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Benitec Biopharma
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 RNAi for Therapeutic Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Benitec Biopharma RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Miragen Therapeutics
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 RNAi for Therapeutic Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Miragen Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed

8 RNAI FOR THERAPEUTIC MANUFACTURING COST ANALYSIS

8.1 RNAi for Therapeutic Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of RNAi for Therapeutic

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 RNAi for Therapeutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RNAI FOR THERAPEUTIC MARKET FORECAST (2016-2021)

12.1 Global RNAi for Therapeutic Production, Revenue Forecast (2016-2021)
12.2 Global RNAi for Therapeutic Production, Consumption Forecast by Regions (2016-2021)
12.3 Global RNAi for Therapeutic Production Forecast by Type (2016-2021)
12.4 Global RNAi for Therapeutic Consumption Forecast by Application (2016-2021)
12.5 RNAi for Therapeutic Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of RNAi for Therapeutic
Figure Global Production Market Share of RNAi for Therapeutic by Type in 2015
Figure Product Picture of siRNA
Table Major Manufacturers of siRNA
Figure Product Picture of miRNA
Table Major Manufacturers of miRNA
Figure Product Picture of shRNA
Table Major Manufacturers of shRNA
Table RNAi for Therapeutic Consumption Market Share by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global RNAi for Therapeutic Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global RNAi for Therapeutic Capacity of Key Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global RNAi for Therapeutic Capacity of Key Manufacturers in 2015
Figure Global RNAi for Therapeutic Capacity of Key Manufacturers in 2016
Table Global RNAi for Therapeutic Production of Key Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Production Share by Manufacturers (2015 and 2016)
Figure 2015 RNAi for Therapeutic Production Share by Manufacturers
Figure 2016 RNAi for Therapeutic Production Share by Manufacturers
Table Global RNAi for Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global RNAi for Therapeutic Revenue Share by Manufacturers
Table 2016 Global RNAi for Therapeutic Revenue Share by Manufacturers
Table Global Market RNAi for Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market RNAi for Therapeutic Average Price of Key Manufacturers in 2015
Table Manufacturers RNAi for Therapeutic Manufacturing Base Distribution and Sales Area
Table Manufacturers RNAi for Therapeutic Product Type
Figure RNAi for Therapeutic Market Share of Top 3 Manufacturers
Figure RNAi for Therapeutic Market Share of Top 5 Manufacturers
Table Global RNAi for Therapeutic Capacity by Regions (2011-2016)
Figure Global RNAi for Therapeutic Capacity Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Capacity Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Capacity Market Share by Regions
Table Global RNAi for Therapeutic Production by Regions (2011-2016)
Figure Global RNAi for Therapeutic Production and Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Production Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Production Market Share by Regions
Table Global RNAi for Therapeutic Revenue by Regions (2011-2016)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2011-2016)
Table 2015 Global RNAi for Therapeutic Revenue Market Share by Regions
Table Global RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table North America RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table China RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table India RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Global RNAi for Therapeutic Consumption Market by Regions (2011-2016)
Table Global RNAi for Therapeutic Consumption Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Consumption Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Consumption Market Share by Regions
Table North America RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Europe RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table China RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Japan RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table India RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Global RNAi for Therapeutic Production by Type (2011-2016)
Table Global RNAi for Therapeutic Production Share by Type (2011-2016)
Figure Production Market Share of RNAi for Therapeutic by Type (2011-2016)
Figure 2015 Production Market Share of RNAi for Therapeutic by Type
Table Global RNAi for Therapeutic Revenue by Type (2011-2016)
Table Global RNAi for Therapeutic Revenue Share by Type (2011-2016)
Figure Production Revenue Share of RNAi for Therapeutic by Type (2011-2016)
Figure 2015 Revenue Market Share of RNAi for Therapeutic by Type
Table Global RNAi for Therapeutic Price by Type (2011-2016)
Figure Global RNAi for Therapeutic Production Growth by Type (2011-2016)
Table Global RNAi for Therapeutic Consumption by Application (2011-2016)
Table Global RNAi for Therapeutic Consumption Market Share by Application (2011-2016)
Figure Global RNAi for Therapeutic Consumption Market Share by Application in 2015
Table Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
Figure Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2011-2016)
Table Arrowhead Research Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead Research RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arrowhead Research RNAi for Therapeutic Market Share (2011-2016)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Silence Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Silence Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Silence Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Benitec Biopharma RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Benitec Biopharma RNAi for Therapeutic Market Share (2011-2016)
Table Miragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Miragen Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Miragen Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure Global RNAi for Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Global RNAi for Therapeutic Production Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Consumption Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Production Forecast by Type (2016-2021)
Table Global RNAi for Therapeutic Consumption Forecast by Application (2016-2021)